Page 138 - pharma 1 theoretical updated MNU_Neat
P. 138

Clinical pharmacy 2024/2025                            Level 3 Pharm D                             Pharmacology 1 (PO 502)

          Dofetilide

                         +
             ➢  Pure K  channel blocker so prolonged APD → ERP
                                                                               .
             ➢  No extracardiac effects (because of selectivity).
             Uses  :

                                                                           .
              Converts atrial flutter & AF to normal sinus rhythm
              Maintains normal sinus rhythm after electrical cardioversion
                                                                                     .
             ADRs
                       :

              risk of polymorphic ventricular tachycardia (Torsade de pointes)

































                                  4-  Class IV - Calcium-channel blockers



                                            verapamil and diltiazem

           ➢ Verapamil shows greater action on the heart than on vascular smooth muscle, and
              diltiazem is intermediate in its actions.

           ➢ Prolong AV nodal conduction time and effective refractory period
           ➢ Decrease rate of phase 4 spontaneous depolarization.

                                  ➢  Supraventricular tachycardia is the major arrhythmia
              Therapeutic            indication for verapamil.
                  uses:           ➢  Verapamil can induce AV block when used in large doses




                                                                                                     | P a g e    -  122 -
   133   134   135   136   137   138   139   140   141   142   143